Target intelligence / Profile preview

RNA, U6 small nuclear 1171, pseudogene (RNU6-1171P)

Target: RNU6-1171P
Molecular classification: Other (non-coding RNA pseudogene)

Overview

RNA, U6 small nuclear 1171, pseudogene (RNU6-1171P) is a genomic locus considered a pseudogene—an imperfect copy or remnant—of the gene encoding U6 small nuclear RNA (snRNA)[4][5]. U6 snRNA itself is a highly conserved component of the spliceosome machinery in eukaryotic cells, but RNU6-1171P does not encode a functional RNA or protein and is not implicated in canonical biological processes or disease mechanisms. The widespread presence of U6 snRNA pseudogenes in the human genome reflects evolutionary gene duplication rather than biological function[3][4]. Most pseudogenes, including RNU6-1171P, are not transcribed into functional molecules, do not serve as drug targets, and lack defined disease associations, biomarkers, or therapeutic relevance[6].

Other names: RNU6-1171P[4][5]

Mechanism of action

None established

Biological functions

None established; pseudogenes generally non-functional, sometimes act as competitive endogenous RNAs (ceRNAs) or microRNA sponges in exceptional cases, but this is not described for RNU6-1171P itself[6]

Disease associations

None directly linked; some pseudogenes are aberrantly expressed in cancer or can play a regulatory role, but this is documented mainly for other pseudogenes, not RNU6-1171P[6]

Safety considerations

None noted; pseudogenes are not drug targets

Interacting drugs

None reported

Biomarkers

None reported for patient selection or efficacy monitoring

Beyond the preview

Go deeper on RNA, U6 small nuclear 1171, pseudogene (RNU6-1171P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1171, pseudogene (RNU6-1171P).

Explore the full profile